09:52 AM EDT, 10/22/2025 (MT Newswires) -- (Updates with latest stock movement in the headline and first paragraph.)

Boston Scientific ( BSX ) shares were up 3.7% in early Wednesday trading after the company posted Q3 adjusted earnings and sales that topped analysts' estimates and lifted its outlook for fiscal 2025.

The company reported Q3 adjusted earnings of $0.75 per diluted share, up from $0.63 a year earlier. Analysts polled by FactSet expected $0.71.

Sales for the quarter ended Sept. 30 were $5.07 billion, up from $4.21 billion a year earlier. Analysts surveyed by FactSet expected $4.97.

For Q4, the biotech firm said it expects adjusted EPS of $0.77 to $0.79. Analysts polled by FactSet estimate $0.76. The company projects Q4 sales growth of 14.5% to 16.5%.

For 2025, Boston Scientific ( BSX ) lifted its adjusted EPS guidance to between $3.02 and $3.04 from a prior estimate of $2.95 to $2.99. Analysts polled by FactSet expect $2.98. The company also raised its sales growth guidance to 20% from 18% to 19%.

Price: 103.61, Change: +3.71, Percent Change: +3.71